The First Example of a Supramolecular Structure Containing [2-(1H-Pyrazol-3-yl)-pyridine] Complex and both α-and β-Octamolybdates

被引：0

作者：

赵文秀 ^{[1
]}

董顺福 ^{[1
]}

张伟萍 ^{[1
]}

彭军 ^{[2
]}

庞海军 ^{[2
]}

机构：

[1] Faculty of Pharmacy, Jilin Medical College

[2] Key Laboratory of Polyoxometalate Science of Ministry of Education, Faculty of Chemistry, Northeast Normal University

来源：

Chinese Journal of Structural Chemistry | 2009年 / 08期

基金：

中国国家自然科学基金;

关键词：

crystal structure; octamolybdate; 2-(1H-pyrazol-3-yl)-pyridine; supramolecular network; nickel(Ⅱ) complex;

D O I：

10.14102/j.cnki.0254-5861.2009.08.020

中图分类号：

O621.2 [有机化合物性质];

学科分类号：

070303 ; 081704 ;

摘要：

The title compound,[Ni(C8N3H7)3]4[Mo8O26]2·6H2O 1,has been synthesized from the reaction of 2-(1H-pyrazol-3-yl)-pyridine (L) with (NH4)2MoO4·2H2O and NiCl2·6H2O. Elemental analysis,IR,UV spectra and X-ray single-crystal diffraction were carried out to determine the composition and crystal structure of the compound. Crystal data:C96H96Mo16N36Ni4O58,Mr = 4451.97,monoclinic system,space group P21/n,a = 20.846(5),b = 14.825(5),c = 23.122(5),β = 91.594(5)°,V = 7143(3) 3,Z = 2,F(000) = 4344,Dc = 2.070 g/cm3,μ = 1.968 mm-1,R = 0.0452 and wR = 0.1056 for 17102 independent reflections (Rint = 0.0442) and 11074 observed reflections (Ⅰ > 2σ(Ⅰ)). Structural analysis indicates that two kinds of octamolybdates ([α-Mo8O26]4-and [β-Mo8O26]4-) co-exist in the compound. This is the first example of a supramolecular structure containing L complex as well as both α-and β-octamolybdate clusters.

引用

页码：1013 / 1017

页数：5

共 50 条

[11] 2-[1-(4,6-dimethoxypyrimidin-2-yl)-1H-pyrazol-3-yl]phenol
Li, Yuan-Xiang
Wang, Ya-Zhou
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2007, 63 : O873 - O874
[12] The crystal structure of chlorido(2-(1H-pyrazol-3-yl)phenolato-κ2N,O)(2-(1H-pyrazol-3-yl)phenol-κN)copper(II), C18H15ClCuN4O2
Li, Wu-Wu
Zheng, Min-Yan
Zhang, Zun-Ting
ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2018, 233 (04): : 735 - 737
[13] Crystal structure of 2-[bis(1H-pyrazol-1-yl)methyl]pyridine
Son, Kyung-sun
Park, Jong-Eun
Kim, Daeyoung
Kang, Sung Kwon
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2015, 71 : O567 - +
[14] Cytotoxic and immunomodulatory potential of a novel [2-(4-(2,5-dimethyl-1H-pyrrol-1-yl)-1H-pyrazol-3-yl)pyridine] in myeloid leukemia
de Castro Alves, Carlos Eduardo
Koidan, Georgyi
Hurieva, Anastasiia N.
de Freitas Gomes, Alice
de Oliveira, Regiane Costa
Costa, Allyson Guimaraes
Boechat, Antonio Luiz Ribeiro
Zahorulko, Serhii
Kostyuk, Aleksandr
Pontes, Gemilson Soares
de Oliveira, Andre Correa
BIOMEDICINE & PHARMACOTHERAPY, 2023, 162
[15] 4-(1H-Pyrazol-3-yl) pyridine-terephthalic acid-water (2/1/2)
Tan, Zheng-De
Tan, Feng-Jiao
Tan, Bo
Zhang, Cheng-Ming
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O1942 - +
[16] Supramolecular assembly and transfer hydrogenation catalysis with ruthenium(II) complexes of 2,6-di(1H-pyrazol-3-yl)pyridine derivatives
Roberts, Thomas D.
Halcrow, Malcolm A.
POLYHEDRON, 2016, 103 : 79 - 86
[17] 2-[5-(2,2-Dimethylpropanamido)-1H-pyrazol-3-yl]pyridinium chloride
Pask, Christopher M.
Kilner, Colin A.
Halcrow, Malcolm A.
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2007, 63 : O2933 - U2702
[18] 2-[(3,5-Diphenyl-1H-pyrazol-1-yl)-methyl]pyridine
Guzei, Ilia A.
Okemwa, Teddy T.
Ojwach, Stephen O.
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O1190 - +
[19] Dichloridobis[4-(1H-pyrazol-3-yl)pyridine-κN1]zinc
Tan, Zheng-De
Tan, Feng-Jiao
Tan, Bo
Zhang, Cheng-Ming
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : M1408 - U1035
[20] Bis-cyclometallated Ir(III) complexes containing 2-(1H-pyrazol-3-yl)pyridine ligands; influence of substituents and cyclometallating ligands on response to changes in pH
Abdolla, Noreldin S. Y.
Davies, David L.
Lowe, Mark P.
Singh, Kuldip
DALTON TRANSACTIONS, 2020, 49 (34) : 12025 - 12036

← 1 2 3 4 5 →